ESN-B/B1

N/A

Report date: 2024/12/03 15:47:23
NMEFirst In Class

Base Information

Drug NameESN-B/B1
Drug Alias NameESN-B/B1
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsChronic Pain
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesEnveda Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesEnveda Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsChronic Pain
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A